Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (5700)
ARDELYX, INC. (ARDX)
Hohenleitner Susan — Chief Financial Officer
Shares
1,558
Price
$3.86
Total Value
$6.01K
Shares Held After
227,520
% of Holdings
0.7%
ARDELYX, INC. (ARDX)
Foster Eric Duane — Chief Commercial Officer
Shares
2,575
Price
$3.86
Total Value
$9.93K
Shares Held After
409,410
% of Holdings
0.6%
ARDELYX, INC. (ARDX)
Foster Eric Duane — Chief Commercial Officer
Shares
3,389
Price
$3.86
Total Value
$13.07K
Shares Held After
411,985
% of Holdings
0.8%
ARDELYX, INC. (ARDX)
Foster Eric Duane — Chief Commercial Officer
Shares
2,598
Price
$3.86
Total Value
$10.02K
Shares Held After
415,374
% of Holdings
0.6%
ARDELYX, INC. (ARDX)
Bishop John E — Chief Technical and Quality Officer
Shares
2,469
Price
$3.86
Total Value
$9.52K
Shares Held After
317,095
% of Holdings
0.8%
ARDELYX, INC. (ARDX)
Bishop John E — Chief Technical and Quality Officer
Shares
17,281
Price
$3.86
Total Value
$66.65K
Shares Held After
319,564
% of Holdings
5.1%
Ceribell, Inc. (CBLL)
Manni Joseph S. — Chief Revenue Officer
Shares
1,361
Price
$24.02
Total Value
$32.69K
Shares Held After
55,956
% of Holdings
2.4%
Ceribell, Inc. (CBLL)
Blumberg Scott — Chief Financial Officer
Shares
1,521
Price
$24.02
Total Value
$36.53K
Shares Held After
146,600
% of Holdings
1.0%
ARDELYX, INC. (ARDX)
Reilly Joseph James — Senior Vice President and Chief Accounting Officer
Shares
1,110
Price
$3.86
Total Value
$4.28K
Shares Held After
145,854
% of Holdings
0.8%
ARDELYX, INC. (ARDX)
Reilly Joseph James — Senior Vice President and Chief Accounting Officer
Shares
2,872
Price
$3.86
Total Value
$11.08K
Shares Held After
146,964
% of Holdings
1.9%
Ceribell, Inc. (CBLL)
Woo Raymond — Chief Technology Officer
Shares
1,979
Price
$24.02
Total Value
$47.54K
Shares Held After
194,729
% of Holdings
1.0%
Ceribell, Inc. (CBLL)
Foehr David — Senior VP, Finance and PAO
Shares
993
Price
$24.02
Total Value
$23.85K
Shares Held After
36,758
% of Holdings
2.6%
ARDELYX, INC. (ARDX)
RAAB MICHAEL — Director
Shares
19,178
Price
$3.86
Total Value
$73.97K
Shares Held After
1,619,792
% of Holdings
1.2%
ARDELYX, INC. (ARDX)
RAAB MICHAEL — Director
Shares
8,411
Price
$3.86
Total Value
$32.44K
Shares Held After
1,638,970
% of Holdings
0.5%
ARDELYX, INC. (ARDX)
RAAB MICHAEL — Director
Shares
15,976
Price
$3.86
Total Value
$61.62K
Shares Held After
1,647,381
% of Holdings
1.0%
ARDELYX, INC. (ARDX)
RAAB MICHAEL — Director
Shares
15,009
Price
$3.86
Total Value
$57.89K
Shares Held After
1,663,357
% of Holdings
0.9%
OMEROS CORP (OMER)
Borges David J. — VP, Finance&CAO
Shares
10,000
Price
$18.95
Total Value
$189.50K
Shares Held After
0
% of Holdings
100.0%
Mineralys Therapeutics, Inc. (MLYS)
Warren Eric — Chief Commercial Officer
Shares
7,437
Price
$25.98
Total Value
$193.19K
Shares Held After
38,400
% of Holdings
16.2%
electroCore, Inc. (ECOR)
Lev Joshua S. — CFO and Interim President
Shares
12,000
Price
$10.22
Total Value
$122.64K
Shares Held After
84,889
% of Holdings
12.4%
PRECIGEN, INC. (PGEN)
AGEE NANCY H — Director
Shares
3,411
Price
$7.23
Total Value
$24.66K
Shares Held After
309,187
% of Holdings
1.1%
Heartflow, Inc. (HTFL)
Farquhar John C.M. — Director
Shares
27,230
Price
$50.00
Total Value
$1.36M
Shares Held After
360,814
% of Holdings
7.0%
PRECIGEN, INC. (PGEN)
Shah Rutul R — Chief Operating Officer
Shares
34,658
Price
$7.50
Total Value
$259.94K
Shares Held After
465,012
% of Holdings
6.9%
Allogene Therapeutics, Inc. (ALLO)
Douglas Earl Martin — SVP, General Counsel
Shares
29,697
Price
$2.12
Total Value
$62.96K
Shares Held After
488,267
% of Holdings
5.7%
Liquidia Corp (LQDA)
Adair Jason — Chief Business Officer
Shares
41,832
Price
$69.09
Total Value
$2.89M
Shares Held After
174,606
% of Holdings
19.3%
Liquidia Corp (LQDA)
Adair Jason — Chief Business Officer
Shares
31,799
Price
$69.09
Total Value
$2.20M
Shares Held After
216,438
% of Holdings
12.8%
Tempus AI, Inc. (TEM)
Fukushima Ryan — CEO, Data
Shares
14,286
Price
$70.00
Total Value
$1.00M
Shares Held After
47,420
% of Holdings
23.2%
Medpace Holdings, Inc. (MEDP)
Troendle August J. — Director
Shares
13,995
Price
$624.45
Total Value
$8.74M
Shares Held After
547,200
% of Holdings
2.5%
UNITEDHEALTH GROUP INC (UNH)
Conway Patrick Hugh — Chief Executive Officer, Optum
Shares
1,169
Price
$390.00
Total Value
$455.91K
Shares Held After
15,328
% of Holdings
7.1%
Twist Bioscience Corp (TWST)
Laponis Adam — Chief Financial Officer
Shares
1,965
Price
$139.07
Total Value
$273.26K
Shares Held After
108,633
% of Holdings
1.8%
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)
Satchi-Fainaro Ronit — Director
Shares
415
Price
$37.25
Total Value
$15.46K
Shares Held After
111,986
% of Holdings
0.4%
Twist Bioscience Corp (TWST)
Leproust Emily M. — Director
Shares
6,639
Price
$139.07
Total Value
$923.26K
Shares Held After
812,299
% of Holdings
0.8%
Twist Bioscience Corp (TWST)
Finn Patrick John — President and COO
Shares
4,046
Price
$139.07
Total Value
$562.66K
Shares Held After
210,802
% of Holdings
1.9%
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)
Weiss Amir — Chief Accounting Officer
Shares
2,500
Price
$37.63
Total Value
$94.08K
Shares Held After
13,071
% of Holdings
16.1%
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)
Weiss Amir — Chief Accounting Officer
Shares
6,945
Price
$37.61
Total Value
$261.22K
Shares Held After
13,071
% of Holdings
34.7%
Twist Bioscience Corp (TWST)
Green Paula — SVP of Human Resources
Shares
1,360
Price
$139.07
Total Value
$189.13K
Shares Held After
117,921
% of Holdings
1.1%
Lyell Immunopharma, Inc. (LYEL)
Lee Gary K. — Chief Scientific Officer
Shares
1,457
Price
$15.54
Total Value
$22.64K
Shares Held After
16,220
% of Holdings
8.2%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
126
Price
$212.06
Total Value
$26.72K
Shares Held After
61,424
% of Holdings
0.2%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
229
Price
$211.46
Total Value
$48.43K
Shares Held After
61,550
% of Holdings
0.4%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
126
Price
$210.40
Total Value
$26.51K
Shares Held After
61,779
% of Holdings
0.2%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
1,405
Price
$209.27
Total Value
$294.02K
Shares Held After
61,905
% of Holdings
2.2%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
937
Price
$208.36
Total Value
$195.23K
Shares Held After
63,310
% of Holdings
1.5%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
177
Price
$207.25
Total Value
$36.68K
Shares Held After
64,247
% of Holdings
0.3%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
127
Price
$212.06
Total Value
$26.93K
Shares Held After
61,424
% of Holdings
0.2%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
245
Price
$211.47
Total Value
$51.81K
Shares Held After
61,551
% of Holdings
0.4%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
136
Price
$210.40
Total Value
$28.61K
Shares Held After
61,796
% of Holdings
0.2%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
1,351
Price
$209.28
Total Value
$282.74K
Shares Held After
61,932
% of Holdings
2.1%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
951
Price
$208.36
Total Value
$198.15K
Shares Held After
63,283
% of Holdings
1.5%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
190
Price
$207.25
Total Value
$39.38K
Shares Held After
64,234
% of Holdings
0.3%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
3,621
Price
$212.08
Total Value
$767.93K
Shares Held After
267,330
% of Holdings
1.3%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
6,583
Price
$211.33
Total Value
$1.39M
Shares Held After
270,951
% of Holdings
2.4%
Showing 51–100 of 5700 transactions (page 2 of 114)